Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-09-10

Clinical Trial Update: Gabapentin for Headache in Aneurysmal Subarachnoid Hemorrhage [Phase 4]

View source ↗

Summary

Phase 4 trial investigating gabapentin for headache management after aneurysmal subarachnoid hemorrhage has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: Mayo Clinic | Conditions: Aneurysmal Subarachnoid Hemorrhage | Phase 4 | Status: COMPLETED | Results posted: 2019-09-10